End-Stage Kidney Disease

LONG BEACH, Calif. — Gaurav Jain, MD, of the University of Alabama at Birmingham discussed value-based care in nephrology at the National Kidney Foundation Spring Clinical Meetings, here.

Apolipoprotein L1 genotype may not be a major factor for future risk of kidney disease in middle-aged adults, according to data from a longitudinal cohort study.

SAN DIEGO — Researchers at Satellite Healthcare and Stanford University School of Medicine have developed a discontinuation risk assessment process to help keep patients on peritoneal dialysis, according to a presentation here.

Use of an electronic health record-based intervention among patients with chronic kidney disease led to greater use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers but did not slow progression of the disease.

Adults with diabetes who are forced to switch to a high-deductible health insurance plan have higher risk for diabetes-related complications than those who remain on a regular health plan, according to study data.

Healio | Nephrology News & Issues recently interviewed Mahesh Krishnan, MD, MPH, MBA, the new chair of Kidney Care Partners, about goals for the advocacy group in the coming year.

Patients with type 2 diabetes and chronic kidney disease receiving empagliflozin were less likely to experience a decline in eGFR compared with patients taking placebo, results from a newly published study show.

Healio has compiled a list of its most-read nephrology care news in 2023.

“The most important skill you will learn in your medical career is to measure blood pressure. Do it correctly and you will help more patients to better health than with any other skill you learn. Do it wrong and you will harm more patients than with any other medical errors you make over your career.” — Clarence E. Grim, MD

Value-based kidney care company Interwell Health has formed a joint venture with Oak Street Health to bring primary care services into the dialysis clinic, according to a press release.